Analystreport

Evelo Biosciences, Inc. (NASDAQ: EVLO) had its price target lowered by analysts at BMO Capital Markets from $10.00 to $5.00.

Evelo Biosciences, Inc.  (EVLO) 
Last evelo biosciences, inc. earnings: 2/13 07:00 am Check Earnings Report